Companies › AGIO

AGIOS PHARMACEUTICALS INC (AGIO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001439222 · EDGAR filings · Updated 2026-07-10

AGIOS PHARMACEUTICALS INC (AGIO) has reported institutional ownership of 106.0%, with 232 institutional managers holding positions valued at $2.12B per the latest 13F reporting period.

Latest updates

• 2026-07-10 — Insider transaction reported (Form 4)
• 2026-07-02 — SCHEDULE 13G filed
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-01 — Notice of proposed sale filed (Form 144)
• 2026-06-23 — Insider transaction reported (Form 4)
• 2026-06-23 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, AGIOS PHARMACEUTICALS INC has 232 institutional holders and institutional ownership of 106.0%.

Insider activity

Insiders reported 107 transactions (0 buys, 49 sells) across 15 reporting insiders, with a net reported value of −$5.18M.

Related companies

ALUMIS INC (ALMS) · KINIKSA PHARMACEUTICALS INTL (KNSA) · NEOGEN CORPORATION (NEOG) · ADAPTIVE BIOTECHNOLOGIES COR (ADPT) · ULTRAGENYX PHARMACEUTICAL IN (RARE) · GENEDX HOLDINGS CORP COM CL A (WGS)